VAERS Explorer
Back to explore

Report #2847533

Received Jun 27, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RABRABIES (RABAVERT)NOVARTIS VACCINES AND DIAGNOSTICSUNKUnknown—

Symptoms (1)

Product administered at inappropriate site

Symptom narrative

Patient received last dose of Rabavert, but it was administered in the buttock, instead of the deltoid; Case reference number US-BN-2024-002123 is a spontaneous case initially received from a pharmacist via Med Communication (reference number: USBAV24-1549) on 02-Jul-2024 and concerns a patient of unknown age and gender. The patient's medical history and concomitant medication were not provided. On an unspecified date, the patient was vaccinated with, as reported, last dose of Rabavert (batch number: unknown) at an unknown dose, route and site of administration for unknown indication. As reported, a dose of Rabavert was administered in the buttock, instead of the deltoid (explicitly coded as 'vaccine administered at inappropriate site'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Rabavert. No further information was provided.; Reporter's Comments: A patient of unknown age and gender with a dose of Rabavert was administered in the buttock, instead of the deltoid which is considered as vaccine administered at inappropriate site. Product administered at inappropriate site is considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to Rabavert. The patient's medical history and concomitant medication were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A patient of unknown age and gender with a dose of Rabavert was administered in the buttock, instead of the deltoid which is considered as vaccine administered at inappropriate site. Product administered at inappropriate site is considered listed per company conventions. At this point, it was unknown if the patient experienced any adverse event due to Rabavert. The patient's medical history and concomitant medication were not provided. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.

Medical history

Comments: None.